MedPath

Treatment of Hypertriglyceridemia with Fucus Vesiculosus vs Atorvastati

Phase 3
Conditions
Health Condition 1: E781- Pure hyperglyceridemia
Registration Number
CTRI/2023/07/055898
Lead Sponsor
Central Council for Research in Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Men and women aged 20-65 years.

2.Known case of Hypothyroid, Type 2 Diabetics and Hypertension with control under medication.

3.Other systemic disorders under control with treatment.

4.Women surgically sterile, post-menopausal, are agreed to practice adequate contraception.

5.Written Informed consent from the patient.

6.Cases falling under Mild and Moderate [20]category of Serum Triglyceride levels as per the classification of Endocrine Society 2010

Exclusion Criteria

1.Pregnancy, breastfeeding.

2.Cases with other uncontrolled systemic diseases like Hypothyroidism, Cardiovascular, Endocrinal diseases or systemic infections.

3.Low levels of Vitamin D.

4.Previous history of cardiovascular disease and cerebra stroke.

5.Suffering from known liver disorders.

6.Cases falling under Severe category of Serum Triglycerides levels as per the classification of Endocrine Society 2010.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath